BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

STAAR Surgical Company (STAA) to Present at the 33rd Annual Canaccord Growth Conference


8/5/2013 6:33:12 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MONROVIA, Calif., Aug. 5, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will participate in the 33rd Annual Canaccord Growth Conference at the Intercontinental Hotel in Boston. STAAR's presentation will be on Wednesday, August 14, 2013 at 4:30 p.m. Eastern Time.

Barry G. Caldwell, President and CEO, will review the Company's recent financial results and current business developments. James Francese, Vice President, Global Marketing, will also be attending. STAAR will offer a live webcast of its presentation on the Company's website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 90 days, also at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com or call 626-303-7902.

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.

CONTACT:
Investors
EVC Group
Douglas Sherk, 415-652-9100
Leigh Salvo, 415-568-9348

Media
EVC Group
Chris Gale
646-201-5431

SOURCE STAAR Surgical Company

MONROVIA, Calif., Aug. 5, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will participate in the 33rd Annual Canaccord Growth Conference at the Intercontinental Hotel in Boston. STAAR's presentation will be on Wednesday, August 14, 2013 at 4:30 p.m. Eastern Time.

Barry G. Caldwell, President and CEO, will review the Company's recent financial results and current business developments. James Francese, Vice President, Global Marketing, will also be attending. STAAR will offer a live webcast of its presentation on the Company's website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 90 days, also at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com or call 626-303-7902.

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.

CONTACT:
Investors
EVC Group
Douglas Sherk, 415-652-9100
Leigh Salvo, 415-568-9348

Media
EVC Group
Chris Gale
646-201-5431

SOURCE STAAR Surgical Company



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES